Period:
Draw Mode:
| Volume | 229,254 |
|
|||||
| News | - | ||||||
| Day High | 17.13 | Low High |
|||||
| Day Low | 16.56 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Avid Bioservices Inc | CDMO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.46 | -2.69% | 16.66 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 17.13 | 16.56 | 17.13 | 16.66 | 17.12 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,860 | 229,254 | $ 16.84 | $ 3,861,401 | - | 11.34 - 21.05 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:00:00 | 1 | $ 16.66 | USD |
Avid Bioservices Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.04B | 62.31M | 62.10M | $ 38.02M | $ 3.80k | 0.01 | 8.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -29.07k | - |
Avid Bioservices News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CDMO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 15.76 | 17.39 | 15.27 | 16.55 | 412,552 | 0.90 | 5.71% |
| 1 Month | 17.37 | 17.97 | 14.21 | 15.60 | 479,920 | -0.71 | -4.09% |
| 3 Months | 17.97 | 21.05 | 14.21 | 17.70 | 517,480 | -1.31 | -7.29% |
| 6 Months | 12.59 | 21.05 | 12.40 | 16.46 | 558,354 | 4.07 | 32.33% |
| 1 Year | 13.73 | 21.05 | 11.34 | 16.58 | 587,999 | 2.93 | 21.34% |
| 3 Years | 6.24 | 34.51 | 5.3935 | 18.39 | 602,966 | 10.42 | 166.99% |
| 5 Years | 3.30 | 34.51 | 3.02 | 14.69 | 507,756 | 13.36 | 404.85% |
Avid Bioservices Description
| Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. |